EP1960392 - HETEROCYCLE-SUBSTITUTED 3-ALKYL AZETIDINE DERIVATIVES [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 20.01.2012 Database last updated on 12.08.2024 | Most recent event Tooltip | 20.01.2012 | Withdrawal of application | published on 22.02.2012 [2012/08] | Applicant(s) | For all designated states Merck Sharp & Dohme Corp. 126 East Lincoln Avenue Rahway, NJ 07065 / US | [2010/10] |
Former [2008/35] | For all designated states Merck & Co., Inc. 126 East Lincoln Avenue Rahway, NJ 07065-0907 / US | Inventor(s) | 01 /
BAKER, Robert, K. 126 East Lincoln Avenue Rahway, NJ 07065-0907 / US | 02 /
HALE, Jeffrey, J. 126 East Lincoln Avenue Rahway, NJ 07065-0907 / US | 03 /
MIAO, Shouwu 126 East Lincoln Avenue Rahway, NJ 07065-0907 / US | 04 /
RUPPRECHT, Kathleen, M. 126 East Lincoln Avenue Rahway, NJ 07065-0907 / US | [2008/35] | Representative(s) | Buchan, Gavin MacNicol, et al Merck Sharp & Dohme Limited European Patent Department Hertford Road Hoddesdon Hertfordshire EN11 9BU / GB | [N/P] |
Former [2009/37] | Buchan, Gavin MacNicol, et al Merck Sharp & Dohme Limited European Patent Department Hertford Road Hoddesdon Hertfordshire EN11 9BU / GB | ||
Former [2008/35] | Buchan, Gavin MacNicol, et al Merck & Co., Inc. European Patent Department Hertford Road Hoddesdon, Hertfordshire EN11 9BU / GB | Application number, filing date | 06844541.0 | 22.11.2006 | [2008/35] | WO2006US45341 | Priority number, date | US20050740178P | 28.11.2005 Original published format: US 740178 P | [2008/35] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2007064566 | Date: | 07.06.2007 | Language: | EN | [2007/23] | Type: | A2 Application without search report | No.: | EP1960392 | Date: | 27.08.2008 | Language: | EN | The application published by WIPO in one of the EPO official languages on 07.06.2007 takes the place of the publication of the European patent application. | [2008/35] | Search report(s) | International search report - published on: | EP | 30.08.2007 | Classification | IPC: | C07D403/10, C07D413/10, C07D417/14, A61K31/41, A61K31/4245, A61P25/00 | [2008/35] | CPC: |
C07D257/04 (EP,US);
A61P1/04 (EP);
A61P1/10 (EP);
A61P1/16 (EP);
A61P11/06 (EP);
A61P25/00 (EP);
A61P25/02 (EP);
A61P25/06 (EP);
A61P25/08 (EP);
A61P25/16 (EP);
A61P25/18 (EP);
A61P25/22 (EP);
A61P25/28 (EP);
A61P25/30 (EP);
A61P25/32 (EP);
A61P25/34 (EP);
A61P3/04 (EP);
A61P9/00 (EP);
C07D271/06 (EP,US);
C07D271/07 (EP,US);
C07D271/10 (EP,US);
C07D271/113 (EP,US);
C07D403/10 (EP,US);
C07D413/10 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2008/35] | Extension states | AL | Not yet paid | BA | Not yet paid | HR | 30.06.2008 | MK | Not yet paid | RS | Not yet paid | Title | German: | HETEROZYKLUS-SUBSTITUIERTE 3-ALKYL-AZETIDIN-DERIVATE | [2008/35] | English: | HETEROCYCLE-SUBSTITUTED 3-ALKYL AZETIDINE DERIVATIVES | [2008/35] | French: | DERIVES D' AZETIDINE 3-ALKYL SUBSTITUES PAR HETEROCYCLE | [2008/35] | Entry into regional phase | 30.06.2008 | National basic fee paid | 30.06.2008 | Designation fee(s) paid | 30.06.2008 | Examination fee paid | Examination procedure | 30.06.2008 | Examination requested [2008/35] | 14.08.2008 | Amendment by applicant (claims and/or description) | 09.12.2011 | Application withdrawn by applicant [2012/08] | Fees paid | Renewal fee | 12.11.2008 | Renewal fee patent year 03 | 06.11.2009 | Renewal fee patent year 04 | 22.10.2010 | Renewal fee patent year 05 | 07.11.2011 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [EX]WO2007062193 (MERCK & CO INC [US], et al) [EX] 1-13 * page 1, line 25 - page 2, line 18 * * examples 1-27 * * claim 1 *; | [PX]WO2006119260 (MERCK & CO INC [US], et al) [PX] 1-13 * page 4, line 34 - page 6, line 21 * * claim 1 *; | [DX]WO2005000809 (MERCK & CO INC [US], et al) [DX] 1-13 * page 1, line 8 - page 2, line 24 * * examples 1-153 * * claim 1 *; | [X]WO0164632 (AVENTIS PHARMA SA [FR]) [X] 1-13 * page 45, line 12 - line 20 * * examples 1-85 * * claim 1 * |